Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
HOOKIPA Pharma revenue
HOOKIPA Pharma's revenue is $43.9 million.
What is HOOKIPA Pharma's revenue?
- HOOKIPA Pharma's revenue growth from 2018 to 2024 is 476.04%.
- HOOKIPA Pharma has 109 employees, and the revenue per employee ratio is $403,174.
- HOOKIPA Pharma's peak quarterly revenue was $36.6M in 2024(q1).
- HOOKIPA Pharma peak revenue was $43.9M in 2024.
- HOOKIPA Pharma annual revenue for 2023 was 20.1M, 41.27% growth from 2022.
- HOOKIPA Pharma annual revenue for 2024 was 43.9M, 118.32% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
HOOKIPA Pharma historical revenue
HOOKIPA Pharma's peak revenue was $43.9M in 2024. The peak quarterly revenue was $36.6M in 2024(q1).
HOOKIPA Pharma's revenue increased from $7.6m in 2018 to $43.9M currently. That's a 476.04% change in annual revenue.
HOOKIPA Pharma annual revenue
HOOKIPA Pharma annual revenue over time
| Fiscal year / year | HOOKIPA Pharma revenue |
|---|---|
| 2018 | $7.6M |
| 2019 | $11.9M |
| 2020 | $19.6M |
| 2021 | $18.4M |
| 2022 | $14.2M |
| 2023 | $20.1M |
| 2024 | $43.9M |
Rate HOOKIPA Pharma's financial transparency
HOOKIPA Pharma annual growth
HOOKIPA Pharma saw the greatest revenue growth in 2020, when revenue increased by 63.99%.
HOOKIPA Pharma had the lowest revenue growth in 2022, when revenue changed by -22.76%.
HOOKIPA Pharma annual growth rate over time
| Year | HOOKIPA Pharma growth |
|---|---|
| 2019 | 57%↑ |
| 2020 | 64%↑ |
| 2021 | -6%↓ |
| 2022 | -23%↓ |
| 2023 | 41%↑ |
| 2024 | 118%↑ |
HOOKIPA Pharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
HOOKIPA Pharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | $5.1M |
| 2019 | $2.2M | $4.1M | $2.0M | $3.6M |
| 2020 | $3.7M | $6.7M | $4.0M | $5.2M |
| 2021 | $5.3M | $5.4M | $3.9M | $3.9M |
| 2022 | $1.4M | $2.7M | $2.2M | $7.8M |
| 2023 | $3.2M | $2.7M | $6.9M | $7.4M |
| 2024 | $36.6M | $1.3M | $4.7M | $1.4M |
HOOKIPA Pharma jobs nearby
Do you work at HOOKIPA Pharma?
Did HOOKIPA Pharma meet its revenue projections?
HOOKIPA Pharma financial information
| CEO | Joern Aldag |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 109 |
| Date Founded | 2011 |
| Headquarters | New York, New York |
| Number of Locations | 1 |
| Revenue | $43.9M |
| Net Income | -$64,915,000 |
| Tax Rate | 0.0% |
| Total Assets | $170,454,000 |
| Ticker | HOOK |
HOOKIPA Pharma jobs you might like
HOOKIPA Pharma financing
HOOKIPA Pharma received early financing of $8.2M on 2011-10-18.
| Series | Round size | Date |
|---|---|---|
| Series D - Hookipa Pharma | $37.4M | 02/2019 |
| Series C - Hookipa Pharma | $60M | 12/2017 |
| Series B - Hookipa Pharma | $11.7M | 12/2016 |
| Grant - Hookipa Pharma | $4.9M | 10/2016 |
| Series B - Hookipa Pharma | $23.3M | 11/2013 |
| Series A - Hookipa Pharma | $8.2M | 10/2011 |
HOOKIPA Pharma investors
| Investors | Security type |
|---|---|
| Baker Brothers Advisors LLC | Series D - Hookipa Pharma |
| Samsara BioCapital | Series D - Hookipa Pharma |
| Redmile Group | Series D - Hookipa Pharma |
| Takeda Ventures | Series D - Hookipa Pharma |
| Invus | Series D - Hookipa Pharma |
| Hillhouse Capital Group | Series C - Hookipa Pharma |
| Takeda Ventures | Series C - Hookipa Pharma |
| Sofinnova Partners | Series C - Hookipa Pharma |
| BioMedPartners | Series C - Hookipa Pharma |
| Sirona Capital | Series C - Hookipa Pharma |
HOOKIPA Pharma competitors
HOOKIPA Pharma's top competitor, Satsuma Pharmaceuticals, earned an annual revenue of $492.9M.
HOOKIPA Pharma's smallest competitor is Corvus Pharmaceuticals with revenue of $1.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Corvus Pharmaceuticals | - | $1.0M | 49 | - |
| Cue Biopharma | - | $9.3M | 46 | - |
| Salarius Pharmaceuticals | - | $5.2M | 5 | - |
| Mirati Therapeutics | - | $12.4M | 418 | - |
| Oncorus | - | $8.5M | 50 | - |
| Bolt Biotherapeutics | - | $7.7M | 91 | - |
| Rigel Pharmaceuticals | - | $179.3M | 158 | - |
| Satsuma Pharmaceuticals | - | $492.9M | 5 | - |
| GlobeImmune | - | $6.5M | 22 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of HOOKIPA Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about HOOKIPA Pharma. The employee data is based on information from people who have self-reported their past or current employments at HOOKIPA Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by HOOKIPA Pharma. The data presented on this page does not represent the view of HOOKIPA Pharma and its employees or that of Zippia.
HOOKIPA Pharma may also be known as or be related to HOOKIPA PHARMA INC., HOOKIPA Pharma, HOOKIPA Pharma Inc, HOOKIPA Pharma Inc. and Hookipa Pharma Inc.